Bio

Jim Thomasch joined Dunn Rush & Co. in January 2018 and serves as a Managing Director in the firm’s Medical Technology and Instrumentation practices. Mr. Thomasch has over 25 years of senior executive financial, operating and management consulting experience. He has led and advised medical device and technology companies through all business development stages, including initial and follow-on fund-raising rounds, early-stage research planning, product development, Phase I through Phase III clinical trial designs and implementations, FDA and EMA regulatory approval processes, and domestic and international product launches and post-approval commercialization. Mr. Thomasch most recently served as CFO of Fonative, Inc., a developer of VoIP software for enterprise call centers that was acquired by FINVI in 2021. Previously, he co-founded Inspektor Medical Solutions (“IMS”), a developer of innovative dental imaging technology devices, where he remains active as both a Director and serving in the capacity of President and Chief Operating Officer. Prior to co-founding IMS, Mr. Thomasch also previously held senior executive management positions in a number of other Boston-based medical device technology companies, including Clinquest Inc. (a Clinical Research Organization), PLC Medical Systems, the XRE division of Trex Medical Corporation, and Angiographic Devices Corporation.